Business Wire

Global Water and Wastewater Utilities Take Aim at Climate Change

18.5.2023 16:00:00 EEST | Business Wire | Press release

Share

Water and wastewater utilities are executing ambitious decarbonization goals, according to a new survey of 100 utilities in North America and Europe. Sponsored by global water technology leader Xylem (NYSE: XYL), the survey finds that 75% of respondents intend to achieve greenhouse gas (GHG) reduction goals by 2040 or earlier. 48% of respondents have set a net-zero emissions goal, and 42% have set an emissions reduction goal.

“The water sector has an important role in the global effort to reduce GHG emissions,” said Patrick Decker, President and CEO at Xylem. “Our sector is energy intensive. However, smart application of technology makes it possible to manage water far more efficiently and affordably. Increasingly, utilities are finding ways to deploy technology to become more resilient and reduce emissions, while also addressing many of their operational concerns.”

The implementation of new and innovative products and solutions can help utilities advance their decarbonization strategies. As highlighted in its recently launched 2022 Sustainability Report, Xylem’s cutting-edge technologies have enabled customers to reduce their CO2e footprint by more than 2.8 million metric tons since 2019. Around the world, leading water and wastewater utilities are focusing on such solutions to drive GHG reduction plans.

In Europe, for example, 31% of respondents plan on installing more energy-efficient technologies. Others are leveraging digital solutions, with 29% looking into advanced metering infrastructure (AMI) and leak detection solutions, and 24% turning to treatment system optimization technologies. Similarly in North America, 35% of respondents plan on implementing plant or asset optimization technologies to advance their decarbonization goals.

With 37% of North American respondents citing resilience to extreme storms and floods as a major concern, advanced digital solutions are also helping water managers improve operational and environmental outcomes at an affordable cost. Buffalo Sewer Authority (BSA), U.S., for example, saved $145 million by deploying a smart sewer system that reduced polluted water flowing into its rivers during storm events – ultimately solving a longstanding problem without spending on new infrastructure.

“To bridge resource gaps and serve our communities as efficiently as possible, we need to work smarter,” Oluwole A. (OJ) McFoy, BSA General Manager, said. “We have shown this technology is effective and can help ensure that Buffalo is more efficient and prepared for the changing climate and the more intense storms coming our way.”

Many utilities ranked process emissions – such as methane and nitrous oxide – close to last in their priorities for action, despite their significant impact, showing that a better understanding of this issue and technological innovation are needed to tackle total water-sector emissions.

The decarbonization strategies being deployed by these forward-thinking utilities are captured in Xylem’s recent paper, Net Zero – The Race We All Win.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our more than 17,000 diverse employees delivered revenue of $5.5 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Houston Spencer
+1 (914) 240-3046
Houston.Spencer@xylem.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye